New mRNA vaccine for brain cancer triggers a strong immune response | Current Affairs | Vision IAS
News Today Logo

New mRNA vaccine for brain cancer triggers a strong immune response

Posted 11 May 2024

2 min read

Vaccine, developed by scientists at University of Florida, in its first-ever human clinical trial quickly reprogrammed the immune system to glioblastoma, most aggressive and lethal brain tumor.

  • Treatment of brain cancers are challenging due to poor chemotherapy response, debilitating side effects from radiotherapy and surgery.

About mRNA Vaccines

  • mRNA (messenger Ribonucleic Acid) is a genetic molecule that contains instructions or recipe that directs cells to make a protein using its natural machinery.
  • It delivers genetic material, encapsulated in lipid nanoparticles, into body to prompt protein production that match up with parts of pathogen called antigens.
  • Immune system sees these foreign antigens as invaders—dispatching defenders called antibodies and T-cells—and training immune system for potential future attacks.

Other Vaccine Technologies

  • Live-attenuated vaccines: Contain weakened live pathogens from bacteria or viruses. e.g., the measles, mumps, and rubella (MMR) Vaccine.
  • Inactivated vaccines: Uses deactivate live pathogens, creating immunity without causing disease. e.g., Polio vaccines.
  • Viral vector vaccines:  Uses a harmless virus to deliver genetic code to host cells. e.g., Ebola vaccine.
  • Subunit vaccines: Made from a pathogen piece, excluding live pathogens, and can be produced from the original pathogen or recombinantly. e.g., Pneumococcal vaccines.
  • Tags :
  • mRNA
  • mRNA Vaccines
  • Brain Cancer Vaccine
Watch News Today